Innocan Pharma Announces the Completion of its First Full-Scale Manufacturing Run in the US and the Launching of its US Commercial Online Platform
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – February 22, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink:
Read more